This is just getting started. VKTX just reported phase 1 results of their GLP1/GIP dual agonist. It appears effective in reducing liver fat (NASH), plasma lipips and weight. The side effects were mild to moderate.
I haven't looked at the code base, but any issues using this with fundamental data? Ideally, I would like to rank stocks based on reported items - retained earnings, sales, operating margins, etc.
Wouldn't the record label need to the identify the particular copy-write that was violated? The generated music is bound to be very much different then any individual piece.